• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Coalition Offers Broad Framework to Improve Kidney Care

Article

A coalition of patient advocates, dialysis-care providers and manufacturers today will unveil a comprehensive new framework for kidney care across the country that identifies four goals: improve survival, reduce hospitalizations, improve health-related quality of life, and improve patient experience with care.

A coalition of patient advocates, dialysis-care providers and manufacturers today will unveil a comprehensive new framework for kidney care across the country that identifies four goals: improve survival, reduce hospitalizations, improve health-related quality of life, and improve patient experience with care.

Kidney Care Partners—established in 2003 to improve care for people with chronic kidney disease—will release A Strategic Blueprint for Advancing Kidney Care Quality (PDF), after more than a year of work on the ambitious plan. The blueprint will also be the focus of a webinar on world kidney day on March 13.

The blueprint cites data from the U.S. Renal Data System that roughly 615,000 adults and about 9,000 children lived with end-stage renal disease in 2011 and required either dialysis or a transplant to survive. While there have been recent improvements in kidney care, members of Kidney Care Partners thought more needed to be done. At a meeting roughly two years ago, members discussed ways to drive quality in this segment and determined they needed to step back and establish priorities.

Read the full story here: http://bit.ly/1fCi1OL

Source: Modern Healthcare

Related Videos
Chesahna Kindred, MD, MBA, FAAD, board-certified dermatologist, Kindred Hair & Skin Center.
Video 2 - "Payer Needs and Strategies for Evaluating and Covering PDTs"
Video 1 - "Differentiating PDTs from Wellness Apps and Evaluating Efficacy"
Chris Pagnani, MD, PC
Video 4 - "Oral SERDs in Development for ER+/HER2- Metastatic Breast Cancer"
Video 3 - "The Role of Oral SERDs in ER+/HER2- Metastatic Breast Cancer"
Screenshot of Stephen Freedland, MD, during a video interview
"Integrating New PAH Therapies into Clinical Practice"
"Clinical Evidence for Emerging PAH Therapies"
Screenshot of Angela Jia, MD, PhD, during a video interview
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.